Clinician Conflicts of Interest at the Cleveland Clinic: The Context and Functions of Disclosure Policy and What Remains Unknown

Journal of Law, Medicine and Ethics 52 (3):743-749 (2024)
  Copy   BIBTEX

Abstract

Due to their financial incentive, clinicians who earn income from a firm that markets medical devices, pharmaceuticals, tests, etc. might inappropriately prescribe their products or services. The Cleveland Clinic’s conflict of interest (CI) policy creates rules governing clinicians who accept compensation from outside firms that market products they prescribe or use in their practice (hereafter, covered financial relationships). The CI policy is implemented by the Innovation Management and Conflict of Interest Program (IM&COI) (hereafter the Committee).

Categories

Keywords

Reprint years

DOI

10.1017/jme.2024.147

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,247

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Conflicts of Interest in Clinical Practice: Cleveland Clinic Policy and Experience.Kathleen A. Derwin, Cory Anand, Susannah L. Rose & Raed Dweik - 2024 - Journal of Law, Medicine and Ethics 52 (3):734-742.
Conflicts of interest: challenges and solutions in business, law, medicine, and public policy.Don A. Moore (ed.) - 2005 - New York: Cambridge University Press.
Conflicts of interest and the (in)dependence of experts advising government on immunization policies.Jean-Christophe Bélisle-Pipon, Louise Ringuette, Anne-Isabelle Cloutier, Victoria Doudenkova & Bryn Williams-Jones - 2018 - Vaccine 36 (49):7439-44.
Managing Conflicts of Interest Should Begin with Dialogue and Education, Not Punitive Measures: Comment on “Toward a Sociology of Conflict of Interest in Medical Research” by Sarah Winch and Michael Sinnott.Ghislaine Mathieu & Bryn Williams-Jones - 2012 - Journal of Bioethical Inquiry 9 (2):221-222.
Disclosure of potential conflicts of interest in biomedical publications in view of the international committee of medical journal editors recommendations.Takako Kojima - 2021 - Central Asian Journal of Medical Hypotheses and Ethics 2 (1):18-22.
Coming clean but playing dirtier : the shortcomings of disclosure as a solution to conflicts of interest.Daylian M. Cain, George Loewenstein & Don A. Moore - 2005 - In Don A. Moore (ed.), Conflicts of interest: challenges and solutions in business, law, medicine, and public policy. New York: Cambridge University Press. pp. 104.
Commentary : financial conflicts of interest and the identity of academic medicine.Scott Y. H. Kim - 2005 - In Don A. Moore (ed.), Conflicts of interest: challenges and solutions in business, law, medicine, and public policy. New York: Cambridge University Press.
Trust and integrity in biomedical research: the case of financial conflicts of interest.Thomas H. Murray & Josephine Johnston (eds.) - 2010 - Baltimore: Johns Hopkins University Press.
The impact of conflict of interest on trust in science.Paul J. Friedman - 2002 - Science and Engineering Ethics 8 (3):413-420.
Defining financial conflicts and managing research relationships: An analysis of university conflict of interest committee decisions.Elizabeth A. Boyd & Lisa A. Bero - 2007 - Science and Engineering Ethics 13 (4):415-435.

Analytics

Added to PP
2024-12-18

Downloads
1 (#1,944,679)

6 months
1 (#1,886,949)

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references